New Issue: Orbital Catastrophe Ahead? Read Now

Dozens of Genes Implicated in Explaining Why Only Some People Develop PTSD

The new identification of possible genetic markers for post-traumatic stress disorder supports treatment with a steroid hormone a few hours after trauma

Join Our Community of Science Lovers!

Most people gradually recover from trauma, but a small fraction of individuals develop post-traumatic stress disorder (PTSD) — prompting scientists to look for the biological underpinnings of this extreme response to traumatic situations such as warfare, car accidents and natural disasters.

Research published on 11 August in Proceedings of the National Academy of Sciences identifies up to 334 genes that may be involved in vulnerability to post-traumatic stress in rats.

Most animal studies of stress use intense stimuli such as electric shocks, designed to produce large, group differences between exposed and unexposed animals. But Nikolaos Daskalakis and his colleagues tried a subtler approach to elicit a wide range of individual responses in rats that had all experienced the same trauma — more closely mimicking the variability of human responses to disturbing events.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


"We wanted to capture the differences between a susceptible individual and one that is not susceptible to the same experience," says Daskalakis, a neuroendocrinologist at the Icahn School of Medicine at Mount Sinai in New York.

The researchers exposed around 100 rats to soiled cat litter — which evokes a feared predator — and tested the animals one week later for lingering effects of the trauma. About one-quarter of the exposed animals were classified as 'extreme' responders, showing high levels of anxiety and startling easily on hearing loud noises. Another quarter of the animals were 'minimal' responders, and exhibited anxiety levels similar to those of non-exposed rats.

To probe the mechanisms that control trauma susceptibility, the researchers used DNA microarray technology to screen 22,000 genes in samples from the blood, and the amygdala and hippocampus — brain areas that are involved in fear and memory. In males and females, and across the different tissues, anywhere from 86 to 334 genes showed changes in expression levels that appeared to relate to extreme or minimal responsiveness.

Most genes seemed to be involved in conferring either vulnerability or resilience, but not both. Daskalakis says that the results suggest that at a genomic level, the balance of two different stress-response systems might control individual susceptibility to PTSD.

Testing treatments
On the basis of their analysis, the researchers predicted that expression of the genes associated with trauma vulnerability and resilience is regulated by 73 transcription factors, about one-quarter of which are involved in glucocorticoid receptor signalling. Misregulation of glucocorticoid receptor signalling has long been suspected in PTSD, and some studies have suggested that abnormally low levels of receptor activity is to blame.

"It gives us insight into a genetic marker for PTSD susceptibility and potential treatments targeting activation of the glucocorticoid receptor as a part of therapy," says David Diamond, a behavioral neuroscientist at the University of South Florida in Tampa. Finding better indicators for trauma susceptibility could help researchers to develop and monitor treatments, he says.

Daskalakis's group further tested this hypothesis by injecting rats with corticosterone — a naturally occurring glucocorticoid hormone that is released following stress — one hour after trauma exposure. Seven days later, rats that had received the treatment showed reduced after-effects of the trauma, compared to untreated animals.

The team has also been studying treatment of emergency patients in hospitals who have experienced traumatic events, by testing whether PTSD can be prevented by a single, high dose of cortisol — the primary glucocorticoid hormone in humans — given a few hours after trauma.

This article is reproduced with permission and was first published on August 11, 2014.

Helen Shen is a science writer based in Sunnyvale, Calif. She has contributed to Nature, Science and the Boston Globe.

More by Helen Shen

First published in 1869, Nature is the world's leading multidisciplinary science journal. Nature publishes the finest peer-reviewed research that drives ground-breaking discovery, and is read by thought-leaders and decision-makers around the world.

More by Nature magazine

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe